Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2024-03-07 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于使用暂时闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Huabang Life Health Co., Ltd. regarding the use of temporarily idle own funds for cash management through low-risk, short-term financial products. It details the investment purpose, amount, risk control measures, and board approval. The document is relatively short (1803 characters) and does not contain financial statements or detailed financial data. It is an announcement about a financing or capital management activity rather than a full financial report or audit. Therefore, it fits best under Capital/Financing Update (CAP).
2024-03-07 Chinese
第八届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 17th meeting of the 8th Board of Directors of Huabang Life Health Co., Ltd. It includes voting results on specific agenda items such as the use of temporarily idle funds and the 2024 financial budget report. The document is short (691 characters) and serves as a public notice of board decisions rather than a detailed management report or financial statement. It does not contain financial data or detailed management discussion, nor is it a full annual or interim report. It also references another announcement for cash management details, indicating this is a board meeting resolution announcement. Therefore, the document fits best under Board/Management Information (MANG).
2024-03-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, total amount spent, compliance with regulatory rules, and future intentions to continue the buyback. It references prior announcements about the share repurchase plan but does not contain financial statements or earnings data. The document is short (1241 characters) and focuses on the update of the share buyback activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2024-03-01 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the pledge of shares by the company's controlling shareholder. It details the number of shares pledged, the proportion of shares involved, pledge start and end dates, and related parties. There is no financial report, earnings data, or management discussion. The content fits the description of a share pledge or capital structure update. According to the filing definitions, this corresponds to a Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2024-02-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, total amount spent, and compliance with relevant regulations. It does not contain full financial statements or comprehensive financial analysis but is an update on the share buyback activity. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2024-02-01 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement by Huabang Life Health Co., Ltd. regarding the company's first share repurchase under an approved buyback plan. It details the board meeting approval, the repurchase amount, price limits, and the actual repurchase transaction executed on January 8, 2024, including number of shares, prices, and compliance with regulatory rules. The document is short (1353 characters) and focuses on the share buyback activity, not a financial report or earnings release. It matches the definition of a Transaction in Own Shares (POS) filing, which reports company share repurchase activities.
2024-01-08 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.